De novo tacrolimus-induced thrombotic microangiopathy in the early stage after renal transplantation successfully treated with conversion to everolimus. [electronic resource]
- Pediatric nephrology (Berlin, Germany) Apr 2015
- 693-7 p. digital
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
1432-198X
10.1007/s00467-014-3036-8 doi
Calcineurin Inhibitors--adverse effects Child Drug Substitution Everolimus--therapeutic use Humans Immunosuppressive Agents--therapeutic use Kidney Transplantation Male Tacrolimus--adverse effects Thrombotic Microangiopathies--chemically induced